sTNFr1 test kit
A new test kit for Soluble Tumour Necrosis Factor receptor 1 (sTNFr1) is available for sale. sTNFr1 identifies diabetic patients at high risk of End Stage Renal Disease (ESRD) up to 10 years in advance. Based on a standard ELISA, the test detects circulating levels of sTNFr1 in just a few hours. Early diagnosis of ESRD leads to improved patient outcomes and reduced healthcare costs. The ELISA kit was developed in conjunction with the Joslin Diabetes Center in Boston, USA. 20 years after the onset of overt nephropathy, approximately 20% of diabetic patients will have progressed to ESRD. The sTNFr1 assay will lead to improvements in the way ESRD is detected and managed.
Supplier: EKF Diagnostics
Website:
